Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients

Nina Singh, Robin Avery, Patricia Munoz, Timothy L. Pruett, Barbara Alexander, Richard Jacobs, Jan G. Tollemar, Edward A. Dominguez, Chen M. Yu, David L. Paterson, Shahid Husain, Shimon Kusne, Peter Linden

Research output: Contribution to journalArticle

Abstract

To discern whether the characteristics and outcome of invasive aspergillosis in liver transplant recipients have evolved during the past decade, 26 patients who underwent transplantation during 1990-1995 (known as "the earlier cohort") were compared with 20 patients who underwent transplantation during 1998-2001 (known as "the later cohort"). Twenty-three percent of the Aspergillus infections in the earlier cohort occurred ≥90 days after transplantation, compared with 55% of such infections in the later cohort (P = .026). The earlier cohort was significantly more likely to have disseminated infection (P = .034) and central nervous system (CNS) involvement (P = .0004) than was the later cohort. The mortality rate was significantly higher for the earlier cohort (92%) than for the later cohort (60%; P = .012). Only disseminated infection (not the year of transplantation) approached statistical significance as an independent predictor of outcome. In the current era, invasive aspergillosis occurs later in the posttransplantation period, is less likely to be associated with CNS infection, and is associated with a lower mortality rate, compared with invasive aspergillosis in the early 1990s.

Original languageEnglish (US)
Pages (from-to)46-52
Number of pages7
JournalClinical Infectious Diseases
Volume36
Issue number1
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Aspergillosis
Transplantation
Mortality
Liver
Infection
Central Nervous System Infections
Aspergillus
Central Nervous System
Transplant Recipients

ASJC Scopus subject areas

  • Immunology

Cite this

Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. / Singh, Nina; Avery, Robin; Munoz, Patricia; Pruett, Timothy L.; Alexander, Barbara; Jacobs, Richard; Tollemar, Jan G.; Dominguez, Edward A.; Yu, Chen M.; Paterson, David L.; Husain, Shahid; Kusne, Shimon; Linden, Peter.

In: Clinical Infectious Diseases, Vol. 36, No. 1, 01.01.2003, p. 46-52.

Research output: Contribution to journalArticle

Singh, N, Avery, R, Munoz, P, Pruett, TL, Alexander, B, Jacobs, R, Tollemar, JG, Dominguez, EA, Yu, CM, Paterson, DL, Husain, S, Kusne, S & Linden, P 2003, 'Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients', Clinical Infectious Diseases, vol. 36, no. 1, pp. 46-52. https://doi.org/10.1086/345441
Singh, Nina ; Avery, Robin ; Munoz, Patricia ; Pruett, Timothy L. ; Alexander, Barbara ; Jacobs, Richard ; Tollemar, Jan G. ; Dominguez, Edward A. ; Yu, Chen M. ; Paterson, David L. ; Husain, Shahid ; Kusne, Shimon ; Linden, Peter. / Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. In: Clinical Infectious Diseases. 2003 ; Vol. 36, No. 1. pp. 46-52.
@article{43d9de12e149477db64b1bf11ba175d5,
title = "Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients",
abstract = "To discern whether the characteristics and outcome of invasive aspergillosis in liver transplant recipients have evolved during the past decade, 26 patients who underwent transplantation during 1990-1995 (known as {"}the earlier cohort{"}) were compared with 20 patients who underwent transplantation during 1998-2001 (known as {"}the later cohort{"}). Twenty-three percent of the Aspergillus infections in the earlier cohort occurred ≥90 days after transplantation, compared with 55{\%} of such infections in the later cohort (P = .026). The earlier cohort was significantly more likely to have disseminated infection (P = .034) and central nervous system (CNS) involvement (P = .0004) than was the later cohort. The mortality rate was significantly higher for the earlier cohort (92{\%}) than for the later cohort (60{\%}; P = .012). Only disseminated infection (not the year of transplantation) approached statistical significance as an independent predictor of outcome. In the current era, invasive aspergillosis occurs later in the posttransplantation period, is less likely to be associated with CNS infection, and is associated with a lower mortality rate, compared with invasive aspergillosis in the early 1990s.",
author = "Nina Singh and Robin Avery and Patricia Munoz and Pruett, {Timothy L.} and Barbara Alexander and Richard Jacobs and Tollemar, {Jan G.} and Dominguez, {Edward A.} and Yu, {Chen M.} and Paterson, {David L.} and Shahid Husain and Shimon Kusne and Peter Linden",
year = "2003",
month = "1",
day = "1",
doi = "10.1086/345441",
language = "English (US)",
volume = "36",
pages = "46--52",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients

AU - Singh, Nina

AU - Avery, Robin

AU - Munoz, Patricia

AU - Pruett, Timothy L.

AU - Alexander, Barbara

AU - Jacobs, Richard

AU - Tollemar, Jan G.

AU - Dominguez, Edward A.

AU - Yu, Chen M.

AU - Paterson, David L.

AU - Husain, Shahid

AU - Kusne, Shimon

AU - Linden, Peter

PY - 2003/1/1

Y1 - 2003/1/1

N2 - To discern whether the characteristics and outcome of invasive aspergillosis in liver transplant recipients have evolved during the past decade, 26 patients who underwent transplantation during 1990-1995 (known as "the earlier cohort") were compared with 20 patients who underwent transplantation during 1998-2001 (known as "the later cohort"). Twenty-three percent of the Aspergillus infections in the earlier cohort occurred ≥90 days after transplantation, compared with 55% of such infections in the later cohort (P = .026). The earlier cohort was significantly more likely to have disseminated infection (P = .034) and central nervous system (CNS) involvement (P = .0004) than was the later cohort. The mortality rate was significantly higher for the earlier cohort (92%) than for the later cohort (60%; P = .012). Only disseminated infection (not the year of transplantation) approached statistical significance as an independent predictor of outcome. In the current era, invasive aspergillosis occurs later in the posttransplantation period, is less likely to be associated with CNS infection, and is associated with a lower mortality rate, compared with invasive aspergillosis in the early 1990s.

AB - To discern whether the characteristics and outcome of invasive aspergillosis in liver transplant recipients have evolved during the past decade, 26 patients who underwent transplantation during 1990-1995 (known as "the earlier cohort") were compared with 20 patients who underwent transplantation during 1998-2001 (known as "the later cohort"). Twenty-three percent of the Aspergillus infections in the earlier cohort occurred ≥90 days after transplantation, compared with 55% of such infections in the later cohort (P = .026). The earlier cohort was significantly more likely to have disseminated infection (P = .034) and central nervous system (CNS) involvement (P = .0004) than was the later cohort. The mortality rate was significantly higher for the earlier cohort (92%) than for the later cohort (60%; P = .012). Only disseminated infection (not the year of transplantation) approached statistical significance as an independent predictor of outcome. In the current era, invasive aspergillosis occurs later in the posttransplantation period, is less likely to be associated with CNS infection, and is associated with a lower mortality rate, compared with invasive aspergillosis in the early 1990s.

UR - http://www.scopus.com/inward/record.url?scp=0037235092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037235092&partnerID=8YFLogxK

U2 - 10.1086/345441

DO - 10.1086/345441

M3 - Article

VL - 36

SP - 46

EP - 52

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -